Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Japan Lifeline Co's share price for the quarter that ended in Mar. 2026 was 円1369. Japan Lifeline Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 70 Mil. Therefore, Japan Lifeline Co's market cap for the quarter that ended in Mar. 2026 was 円96,041 Mil.
Japan Lifeline Co's quarterly market cap
increased
from Sep. 2025 (円105,725 Mil) to Dec. 2025 (円110,566 Mil) but then
declined
from Dec. 2025 (円110,566 Mil) to Mar. 2026 (円96,041 Mil).
Japan Lifeline Co's annual market cap
increased
from Mar. 2024 (円91,338 Mil) to Mar. 2025 (円107,108 Mil) but then
declined
from Mar. 2025 (円107,108 Mil) to Mar. 2026 (円96,041 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Japan Lifeline Co's Enterprise Value for Today is 円86,964 Mil.
Japan Lifeline Co (TSE:7575) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Japan Lifeline Co Market Cap Related Terms
Japan Lifeline Co Market Cap Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Japan Lifeline Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Japan Lifeline Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Lifeline Co (TSE:7575) has a Market Cap of 円96,392 Mil as of Jul. 15, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Japan Lifeline Co and its competitors. According to the industry distribution chart, Japan Lifeline Co ranks #244 out of 865 companies in the Medical Devices & Instruments industry, placing it in the top 28.2%.
Is Japan Lifeline Co's Market Cap too high?
Japan Lifeline Co's current Market Cap is 円96,392 Mil. Based on the distribution chart, Japan Lifeline Co ranks #244 out of 865 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Japan Lifeline Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #244 out of 865 companies for Market Cap. This puts Japan Lifeline Co in the upper half of its industry. The industry median Market Cap is 116.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.04, based on 865 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current Market Cap is 円96,392 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Lifeline Co (TSE:7575) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,535.81, compared to a current price of 円1,374.00 — trading 10.5% below its estimated fair value. The current Market Cap is 円96,392 Mil. Japan Lifeline Co's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Japan Lifeline Co (TSE:7575), the current Market Cap is 円96,392 Mil as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (TSE:7575) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of 円1,374.00 is trading 10.5% below its estimated GF Value™ of 円1,535.81.
GuruFocus considers Japan Lifeline Co to be Modestly Undervalued.
Key valuation signals for TSE:7575:
Market Cap: 円96,392 Mil
GF Value™: 円1,535.81 vs. price of 円1,374.00 (10.5% below fair value)
No single metric tells the full story. See the TSE:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score
Get the complete analysis for TSE:7575
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7575 has been successfully added to your 
